Occupational Therapists in Randolph, NJ Accepting Medicare

8 Occupational Therapists found. Showing 1 - 8

Patricia Mygas, OTR Occupational Therapist Medicare: Accepting Medicare Assignments Practice Location: 23 Crestwood Dr, Randolph, NJ 07869 Phone: 973-590-7282

Kathy Wu Occupational Therapist Medicare: Accepting Medicare Assignments Practice Location: 175 Quaker Church Rd, Randolph, NJ 07869 Phone: 973-559-6422

Mr. Scott Cullen Wilson, MS Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 36 Wilkinson Rd, Randolph, NJ 07869 Phone: 973-722-6822

Lynn M Fiore, OTR Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 10 Country Ln, Randolph, NJ 07869 Phone: 973-895-4684

Miss Taylor Raquel Demarco, OTR/L Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 791 Route 10 E, Randolph, NJ 07869 Phone: 973-216-1008

Ms. Debra Joyce Biarsky-karros, OTR Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 43 Carrell Rd, Randolph, NJ 07869 Phone: 973-525-9363

Melissa Rachel Bierman, MS/OTD, OTR/L Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 1101 Sussex Tpke, Randolph, NJ 07869 Phone: 973-214-1653

Nicholas A Mills Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 121 Center Grove Rd Ste 8, Randolph, NJ 07869 Phone: 973-361-5500

News Archive

ZIOPHARM initiates ZIN ATI-001 Phase 1 clinical study in advanced melanoma

ZIOPHARM Oncology, Inc. today announced that the first patient has been dosed in a Phase 1 clinical study of ZIN ATI-001, a novel DNA-based therapeutic candidate, in patients with advanced melanoma.

Ill. fines hospitals for preventable hospital readmissions

Also, a federal lawsuit in California alleges nursing homes overmedicated their residents and seeks repayment. Illinois will be collecting $16.3 million in penalties from 82 hospitals that had too many Medicaid patients readmitted to their hospital, the state said Friday.

FDA approves Gore's C3 Delivery System to deploy EXCLUDER AAA Endoprosthesis

W. L. Gore & Associates (Gore) today announced that it has received approval from the U.S. Food and Drug Administration (FDA) to market the GORE® C3 Delivery System to deploy the GORE® EXCLUDER® AAA Endoprosthesis as a minimally invasive treatment for patients suffering from an abdominal aortic aneurysm (AAA).

Scientists shed light on evolutionary history of multidrug-resistant enterococci bacteria

Enterococci bacteria are the bane of hospitals, causing thousands of multidrug-resistant infections in patients each year.

African-Americans with Medicaid are less likely to receive LKT than patients with private insurance

African-Americans with Medicaid as their primary insurance were less likely to receive a living kidney transplant (LKT) than patients with private insurance, according to a new study by researchers at Wake Forest Baptist Medical Center.

Read more Medical News

› Verified 7 days ago